view article
Figure 1
Molecules used for studying disorder in this work, ordered by CSD refcode: I, methyl (4-bromo­phenyl)(3-tert-butyl-1H-indol-1-yl)acetate; II, erlotinib; III, a cocrystal of MeOPP with 4-fluoro­benzoate and H2O; IV, DL-arginine monohydrate; V, 1-(2-bromo-3-{[tert-butyl­(di­methyl)­silyl]­oxy} phenyl)-2,2-di­methyl­but-3-en-1-yl-4-nitro­benzoate; VI, telaprevir; VII, irbesartan HBr 2H2O; VIII, duloxetine HCl; IX, darifenacin HBr; and X, propionamide.

IUCrJ
Volume 8| Part 2| March 2021| Pages 305-318
ISSN: 2052-2525
https://doi.org/10.1107/S2052252521000531